Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
PubChem
DailyMed
Druglib
Clinicaltrials.gov
Chemistry and Pharma Blogs:
The Science Business
Org Prep Daily
Kilomentor
On Pharma
Kinase Pro
Pharma Conduct
Chemical Quantum Images
The LouRoe
One in Ten Thousand
Periodic Tabloid
Chemical Musings
C&E News Blog
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Chirality

BBSRC/Douglas Kell
Drug Discovery Opinion
The Chemblog
Realizations in Biostatistics
Molecule of the Day
Chemjobber
Pharmalot
WSJ Health Blog
Chemical Crystallinity
ChemSpider Blog
Pharmagossip
Med-Chemist
Organometallic Current
Useful Chemistry
Chiral Jones
Great Molecular Crapshoot
No Name No Slogan
SimBioSys
Culture of Chemistry
The Curious Wavefunction
Chemical Sabbatical
Totally Synthetic
Zusammen
My Chemical Journey
The F- Blog
Generally Chemistry
Chemistry World Blog
Synthetic Nature
Synthesizing Ideas
Carbon-Based Curiosities
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
P212121
Curly Arrow
ChemCafe
Power of Goo
Fetz the Chemist
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa
Pharma Blog Review


Science Blogs and News:
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Life of a Lab Rat
Nobel Intent
SciTech Daily
Is This Thing On?
Science Blog
Eastern Blot
FuturePundit
Flags and Lollipops
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Terra Sigillata
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Living the Scientific Life
Humans in Science
Speculist
Science, Shrimp and Grits
Cosmic Variance
The Capsule
Zeroth Order Approximation
Science Library Blog
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Nobel Fever Is Upon Us | Main | Test Your Skills! »

September 28, 2006

The Horse Latitudes

Email This Entry

Posted by Derek

I haven't given any updates on my side project recently because, well, there hasn't been much to update. Progress has stalled, for several reasons - instrument difficulties, power outages, people (including me) being out of town, resources being shifted around. This sort of work is particularly vulnerable to that sort of thing, because it exists through the sufferance of others. It's always been a "work on this after everything else is taken care of" project, and recently everything else has been having its innings.

I have a backlog of completed experiments in the freezer, waiting for a chance to get run, and I'm working on the design of several more. One thing that window-of-opportunity projects force you to do is make the most of the chances you get, so experimental design becomes more crucial than ever. I can't just run the first thing that comes into my head - odds are that it won't be the optimum use of the time and resources. I can usually think up something better if I spend more time thinking about it. Even so, I've had about all the time to think that I can handle for now, and I'm working on ways to get things going again.

Another odd feature of this work is the solo nature of it. I'm used to working in teams, which is how the drug industry operates the overwhelming amount of the time. That's because we have to have people who specialize in so many different areas, but there's an operational aspect to it that doesn't get mentioned much. In a team environment, people have to get things done because someone else is waiting on them. The biologists running the assays are waiting on the medicinal chemists for compounds, who are waiting on the assay numbers to see what to do next, and the same goes for formulations, metabolism, the in vivo assays, and all the rest of it.

But working alone is another story. No one is waiting on these results in the same way as in a normal drug discovery project. Many of my colleagues are interested in what's going on, but I'm the main customer for my own data, for now. If I completely stopped doing this project- walked away and never came back - some folks would eventually ask me about whatever happened to that wild idea of mine, but most wouldn't. And it wouldn't take long for the memory of the whole thing to get buried under the steady pile-up of new work.

No, no one's pressing me to do this but me. It's a different sensation from the industrial research I'm used to. For everything else I've worked on, I've known that if I left the project it would roll along without me, but not this time. This idea would die immediately if I took my shoulder off the wheel, but I'm not going to let that happen.

Comments (1) + TrackBacks (0) | Category: Birth of an Idea


COMMENTS

1. otey2 on September 29, 2006 10:38 AM writes...

Good.

Thanks for the update.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Dealing With Hedgehog Screening Results
Animal Rights, You Say?
Blogroll Update
Pharma's Return on Investment: Yikes
How A Real Drug Industry Project Meeting Goes
Ghostwriting
Just Give It to NIH
How Not To Do It: The Secret Patent Decoder Ring